BioPharma Dive 2026-02-02 Building a robust in-process testing plan for cell therapy manufacturing success
BioPharma Dive 2026-01-30 AstraZeneca leans into obesity, striking wide-ranging alliance with China’s CSPC
BioPharma Dive 2026-01-28 Lilly bets on Seamless, delving further into genetic medicine for hearing loss
BioPharma Dive 2026-01-26 Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time
BioPharma Dive 2026-01-26 The formula for biotech success in 2026: Confidence, resilience and funding